Chair of the Board · Astria Therapeutics, Inc. (ATXS)

Kenneth Bate director compensation at Astria Therapeutics: $177K

Fiscal year 2024 director compensation for Kenneth Bate at Astria Therapeutics, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Kenneth Bate’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Kenneth Bate and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Astria Therapeutics Director Compensation Table · the one fiscal year held
In US dollars, as Astria Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$90,500$0$86,980$0$177,480

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Astria Therapeutics, Inc. DEF 14A filed April 28, 2025, accession 0001104659-25-040180, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Astria Therapeutics, Inc. filed document, accession 0001104659-25-040180. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

Get the Astria Therapeutics Board Governance Report

$177,480 Kenneth Bate, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

Astria Therapeutics pays directors a $40,000 cash retainer.

Committees

FY2024 · as the proxy prints them

Audit

The rest of the Astria Therapeutics board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Fred CalloriIndependent Director$135,980
Gregg LapointeIndependent Director$146,980
Hugh ColeIndependent Director$135,730
Jill C. MilneDirector—
Joanne BeckIndependent Director$139,480
Jonathan ViolinIndependent Director$141,980
Michael KishbauchIndependent Director$140,980
Sunil AgarwalIndependent Director$256,282

The full Astria Therapeutics compensation record

free company brief

This page is one director within Astria Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Astria Therapeutics proxy · each links to its own free brief

Order ATXS

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report